本文選題：中西醫(yī)結(jié)合學(xué)科 + 心血管　； 參考：《中國科學(xué)基金》2017年01期

【摘要】：本文對(duì)2013—2015年度國家自然科學(xué)基金中西醫(yī)結(jié)合學(xué)科心血管領(lǐng)域的面上、青年、地區(qū)科學(xué)基金項(xiàng)目的資助情況進(jìn)行了分析,以期為該領(lǐng)域的研究者提供參考。結(jié)果顯示,國家自然科學(xué)基金中西醫(yī)結(jié)合學(xué)科心血管領(lǐng)域資助項(xiàng)目的數(shù)量、經(jīng)費(fèi)、資助類別與該學(xué)科整體資助情況基本一致,在該領(lǐng)域獲得3項(xiàng)以上資助的依托單位多為中醫(yī)藥專門研究機(jī)構(gòu)。這些項(xiàng)目的主要研究特點(diǎn)包括:從臨床需求出發(fā),緊扣心血管領(lǐng)域研究前沿;復(fù)方是藥物干預(yù)手段的主體,成分組合研究不斷增多;新技術(shù)新方法不斷涌現(xiàn),但理論創(chuàng)新相對(duì)不足。
[Abstract]:This paper analyzes the status of the projects of the National Natural Science Foundation of China in the cardiovascular field of integrated Chinese and Western medicine in 2013-2015 in order to provide a reference for the researchers in this field. The results show that the number, funding, and types of cardiovascular projects supported by the National Natural Science Foundation of China and Western Medicine are basically the same as those of the overall financial support for this discipline. In this field more than 3 support units for Chinese medicine specialized research institutions. The main research features of these projects include: starting from clinical needs, closely following the frontier of cardiovascular research; compound is the main body of drug intervention, and the research of composition combination is increasing; new technologies and methods are emerging constantly. But the theory innovation is relatively insufficient.
【作者單位】： 國家自然科學(xué)基金委員會(huì)醫(yī)學(xué)科學(xué)部;北京中醫(yī)藥大學(xué)基礎(chǔ)醫(yī)學(xué)院;復(fù)旦大學(xué)附屬腫瘤醫(yī)院;

【相似文獻(xiàn)】

相關(guān)會(huì)議論文 前1條

1 郭濤;;心血管領(lǐng)域——充滿挑戰(zhàn)和機(jī)遇…[A];玉溪市第十一屆內(nèi)科學(xué)術(shù)年會(huì)論文集[C];2007年

相關(guān)重要報(bào)紙文章 前4條

1 王丹;勃林格殷格翰發(fā)力心血管領(lǐng)域[N];醫(yī)藥經(jīng)濟(jì)報(bào);2008年

2 本報(bào)記者 鄭穎t，

本文編號(hào)：2110664